Has the core outcome (domain) set for vitiligo been implemented? An updated systematic review on outcomes and outcome measures in vitiligo randomized clinical …
V Eleftheriadou, C Bergqvist… - British Journal of …, 2023 - academic.oup.com
Background In 2015, a major achievement in vitiligo research was the development of an
internationally agreed upon core outcome domain set for randomized clinical trials (RCTs) …
internationally agreed upon core outcome domain set for randomized clinical trials (RCTs) …
Exploring the natural and treatment history of vitiligo: perceptions of patients and healthcare professionals from the global VALIANT study
IH Hamzavi, K Bibeau, P Grimes… - British Journal of …, 2023 - academic.oup.com
Background Vitiligo is a chronic autoimmune disease affecting melanocytes, resulting in skin
depigmentation. Patients with vitiligo often have reduced quality of life and comorbid …
depigmentation. Patients with vitiligo often have reduced quality of life and comorbid …
Phototherapy for vitiligo: A narrative review on the clinical and molecular aspects, and recent literature
Background Vitiligo is characterized by depigmented patches resulting from loss of
melanocytes. Phototherapy has emerged as a prominent treatment option for vitiligo …
melanocytes. Phototherapy has emerged as a prominent treatment option for vitiligo …
Randomized controlled trial of topical corticosteroid and home‐based narrowband ultraviolet B for active and limited vitiligo: results of the HI‐Light Vitiligo Trial
KS Thomas, JM Batchelor, P Akram… - British Journal of …, 2021 - academic.oup.com
Background Evidence for the effectiveness of vitiligo treatments is limited. Objectives To
determine the effectiveness of (i) handheld narrowband UVB (NB‐UVB) and (ii) a …
determine the effectiveness of (i) handheld narrowband UVB (NB‐UVB) and (ii) a …
The effect of lockdown on melanoma stage in Devon, UK
HT Heath, EJ McGrath, P Acheson - Clinical and Experimental …, 2022 - academic.oup.com
effect of lockdown on melanoma stage in Devon, UK | Clinical and Experimental
Dermatology | Oxford Academic Skip to Main Content Advertisement Oxford Academic …
Dermatology | Oxford Academic Skip to Main Content Advertisement Oxford Academic …
Randomised controlled trial of topical corticosteroid and home? based narrowband UVB for active and limited vitiligo: results of the HI? Light Vitiligo trial
KS Thomas, JM Batchelor… - British Journal …, 2020 - nottingham-repository.worktribe.com
Background Evidence for the effectiveness of vitiligo treatments is limited. Objectives To
determine effectiveness of (a) hand‐held narrowband‐UVB (NB‐UVB) and (b) combination …
determine effectiveness of (a) hand‐held narrowband‐UVB (NB‐UVB) and (b) combination …
Prescribing and using vitiligo treatments: lessons from a nested process evaluation within the HI‐Light vitiligo randomized controlled trial
P Leighton, JR Chalmers, JM Batchelor… - Clinical and …, 2022 - academic.oup.com
Abstract Background The HI‐Light Trial demonstrated that for active, limited vitiligo,
combination treatment with potent topical corticosteroid (TCS) and handheld narrowband …
combination treatment with potent topical corticosteroid (TCS) and handheld narrowband …
[HTML][HTML] Современные аспекты лечения витилиго
МА Катина - Вестник Витебского государственного …, 2022 - cyberleninka.ru
Витилиго является приобретенным гипомеланозом с частотой встречаемости 0, 1%-
2% среди взрослого и детского населения во всем мире. В настоящее время витилиго …
2% среди взрослого и детского населения во всем мире. В настоящее время витилиго …
[引用][C] Randomized controlled trial of topical corticosteroid and home-based narrowband ultraviolet B for active and limited vitiligo: results of the HI-Light Vitiligo Trial
P Akram, JC Ravenscroft, A Rogers - 2022 - John Wiley and Sons Ltd
[引用][C] Prescribing and using vitiligo treatments: lessons from a nested process evaluation within the HI-Light vitiligo randomized controlled trial
A Rogers, P Akram, JC Ravenscroft - 2022 - John Wiley and Sons Ltd